Chemoinformaics analysis of 2-Hydroxypropyl 2-ethylhexanoate
| Molecular Weight | 202.294 | nRot | 7 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 1 |
| Exact Molecular Weight | 202.157 | nRing | 0 |
| Solubility: LogS | -2.05 | nHRing | 0 |
| Solubility: LogP | 2.751 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 35.4454 |
| nHD | 1 | BPOL | 24.6746 |
| QED | 0.643 |
| Synth | 3.002 |
| Natural Product Likeliness | 0.437 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.068 |
| HIA | 0.003 |
| CACO-2 | -4.278 |
| MDCK | 0.0000301 |
| BBB | 0.948 |
| PPB | 0.470342 |
| VDSS | 1.143 |
| FU | 0.609168 |
| CYP1A2-inh | 0.536 |
| CYP1A2-sub | 0.569 |
| CYP2c19-inh | 0.298 |
| CYP2c19-sub | 0.791 |
| CYP2c9-inh | 0.104 |
| CYP2c9-sub | 0.616 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.277 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.328 |
| CL | 9.254 |
| T12 | 0.699 |
| hERG | 0.054 |
| Ames | 0.058 |
| ROA | 0.022 |
| SkinSen | 0.389 |
| Carcinogencity | 0.218 |
| EI | 0.517 |
| Respiratory | 0.438 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.550548 |